Hospital Carlos Van Buren
Valparaíso 2352499
1 studies enrolling now · 10 studies all time
What they study most
Acute Ischemic Stroke Patients Receiving Reperfusion Therapy, Aneurysmal Subarachnoid Hemorrhage, Breast Cancer, COVID-19, Cancer, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Relapsing Multiple Sclerosis
Studies at this site
- A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD) — Recruiting now
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Completed
- Optimal Post Tpa-Iv Monitoring in Ischemic Stroke — Completed
- A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed
- Study to Evaluate the Safety and Efficacy of Liquid Alpha1-Proteinase Inhibitor (Human) in Hospitalized Participants With Coronavirus Disease (COVID-19) — Stopped early
- A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard of Care — Stopped early
- ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 — Stopped early
- Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer — Completed
- Clazosentan in Aneurysmal Subarachnoid Hemorrhage — Stopped early
- Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer — Completed